AI assistant
Sending…
Jazz Pharmaceuticals plc — Director's Dealing 2015
Nov 17, 2015
30751_dirs_2015-11-17_81baef73-3a3e-4ef3-8528-2036665166bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-11-13
Reporting Person: McGill Iain (SVP, Europe & Rest of World)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-13 | Ordinary Shares | S | 1621.0 | $135.3717 | Disposed | 20346 | Direct |
| 2015-11-13 | Ordinary Shares | S | 1200.0 | $136.0829 | Disposed | 19146 | Direct |
More from Jazz Pharmaceuticals plc
Regulatory Filings
2026
May 29
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2